In a new series profiling our team of microbiome experts, we have set out to understand microbiome research by asking our bioinformaticians – who have published highly cited papers ranging from topics on paleomicrobiology to semi-industrial profiling of the microbiome. Our bioinformaticians are experts in the human microbiome at birth and in
Diversigen, Inc. and Alimentiv Inc. Announce Collaboration Agreement for Ulcerative Colitis Research Study
ST. PAUL, MN, June 25, 2020 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Alimentiv Inc. (formerly Robarts Clinical Trials) today announced they have signed a collaboration agreement for a research study on patients with Acute Severe Ulcerative Colitis (ASUC). The study, titled: “Pharmacokinetics of Infliximab and
Diversigen Inc. Selected by Nom NomTM as the Preferred Provider for Metagenomics and Microbiome Sequencing and Analysis Services
PAUL, MN and OAKLAND, CA, May 22, 2020 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Nom NomTM, a direct-to-consumer pet health brand, today announced that Nom Nom has selected Diversigen as their preferred provider for metagenomics and microbiome sequencing and analysis services. Diversigen will also serve
DNa Genotek's Podcast & Blogs
Diversigen’s sister company DNA Genotek offers new insights on microbiome, DNA and RNA sample collection, stabilization and services, through their blogs and podcast.
Discover where our services can take you.
Diversigen provides services and generates data for research purposes only. Not all services are available in all regions.